Ending drug companies' addiction to price rises

Article

NEW YORK (Reuters) - Drug companies are dosing up on price increases to prop up stagnant sales, but will soon need to break that addiction as more medicines face generic competition.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.